IUI Schedule in Cases of High Progesterone
IAD-P4
Programming IUI With Sperm Donor in Patients With High Progesterone the Day of hCG Administration
1 other identifier
interventional
70
0 countries
N/A
Brief Summary
Intrauterine insemination (IUI) combined with ovarian stimulation protocols has become one of the first alternative treatment against infertility, although results in gestational terms are highly variable, ranging between 10% and 25%. The influence of progesterone levels in stimulated cycles of intrauterine insemination is an aspect little studied; however, this information may be useful when synchronizing the time of insemination with the implantation window, as it has been observed that patients with elevated levels of progesterone in the follicular phase exhibit a significant decrease in ongoing pregnancy rates, these results being possible due to premature ovulation which causes asynchrony between the embryo and the endometrium. Taking into account these considerations, the aim of the investigators' study is to determine the effectiveness, in terms of ongoing pregnancy rates, to advance the intrauterine insemination with sperm donor (24 hours post-hCG) with respect to the standard schedule (36 hours post-hCG) according progesterone levels determined the day of hCG administration
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2015
CompletedFirst Posted
Study publicly available on registry
May 19, 2015
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedMay 19, 2015
May 1, 2015
1 year
May 7, 2015
May 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ongoing pregnancy rate
1 month
Secondary Outcomes (7)
Doses of gonadotropins
1 day
Estradiol levels the day of hCG administration
1 day
LH levels the day of hCG administration
1 day
Days of stimulation
1 day
Cancellation rate
1 month
- +2 more secondary outcomes
Study Arms (2)
Group 1
OTHERIntrauterine insemination with sperm donor (IAD) at 36 hours post-hCG. Cases where the IAD is scheduled at 36 hours post-administration of hCG.
Group 2
EXPERIMENTALIntrauterine insemination with sperm donor (IAD) at 24 hours post-hCG. Cases where the IAD is scheduled at 24 hours post-administration of hCG.
Interventions
Eligibility Criteria
You may qualify if:
- Body mass index (BMI) 18-30 kg / m2
- Patent tubes
- Regular cycles (26-35 days)
- FSH levels on day 3 of cycle (\<10 mIU / ml)
- Estradiol levels on day 3 of cycle (\<60 pg / ml)
- Progesterone levels the day of hCG (\> 1 ng / ml)
- Semen donors belonging to the bank of IVI
You may not qualify if:
- Patients with ≥3 follicles of over 16 mm diameter
- No dominant follicle after two consecutive ultrasound
- Women with P \<1 ng / ml on the day of hCG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IVI Madridlead
- Vida Recoletas Sevillacollaborator
- IVI Vigocollaborator
Related Publications (4)
Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007 Jul-Aug;13(4):343-55. doi: 10.1093/humupd/dmm007. Epub 2007 Apr 3.
PMID: 17405832BACKGROUNDAntaki R, Dean NL, Lapensee L, Racicot MH, Menard S, Kadoch IJ. An algorithm combining ultrasound monitoring and urinary luteinizing hormone testing: a novel approach for intrauterine insemination timing. J Obstet Gynaecol Can. 2011 Dec;33(12):1248-52. doi: 10.1016/s1701-2163(16)35110-6.
PMID: 22166279RESULTAzem F, Tal G, Lessing JB, Malcov M, Ben-Yosef D, Almog B, Amit A. Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer? Gynecol Endocrinol. 2008 Jul;24(7):368-72. doi: 10.1080/09513590802196353.
PMID: 18645708RESULTBlockeel C, Knez J, Polyzos NP, De Vos M, Camus M, Tournaye H. Should an intrauterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT. Hum Reprod. 2014 Apr;29(4):697-703. doi: 10.1093/humrep/deu022. Epub 2014 Feb 18.
PMID: 24549212RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Requena, PhD, MD
IVI Madrid
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD MD
Study Record Dates
First Submitted
May 7, 2015
First Posted
May 19, 2015
Study Start
July 1, 2015
Primary Completion
July 1, 2016
Study Completion
October 1, 2016
Last Updated
May 19, 2015
Record last verified: 2015-05